| Antigen: | CD86 |
| Clone: | BU63 |
| Subclass | IgG1 |
| Species Raised In: | Balb/c |
| Immunogen: | ARH 77 (B-lymphoblastoid cell line) |
| Cross Reactivity: | Human |
| Applications: | FACS, Frozen, Immunoprecipitation, Western |
| Growth Conditions: | RPMI 1640 + 10% FCS |
| Fusion Partner: | NS1 |
| Relevance: | CD86 is a 70 kDa type I transmembrane glycoprotein belonging to the immunoglobulin superfamily of cell surface receptors. CD86 is expressed on resting monocytes and dendritic cells, activated T and Natural Killer cells, and is rapidly induced on the surface of activated B-cells, suggesting that it is a major CD28 ligand and may play an important role for the co-stimulation of T-cells in the primary immune response. CD86 is also expressed by malignant Hodgkin and Reed Sternberg (HRS) cells in Hodgkin's disease. |
| References: | Caux C. et al. 1994. J.Exp.Med. 180(5):1841-7. PMID: 7525840 Read more |
| Notes: | Recommended for the inhibition of the mixed lymphocyte reaction (MLR) and the binding of soluble CTLA-4 (CD152)-mulg fusion protein to CD 86 (B7-2). |
© Cancer Research Technology 2012